Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732
HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist being…
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 12, 2025 16:30 ET Â | Source: Fulcrum Therapeutics, Inc. CAMBRIDGE, Mass.,…
Cullinan Therapeutics to Participate in Fireside Chat at the Stifel 2025 Virtual Immunology and Inflammation Forum
September 12, 2025 07:00 ET Â | Source: Cullinan Therapeutics, Inc. CAMBRIDGE, Mass.,…
Zai Lab Announces Approval of TIVDAK for Patients with Recurrent or Metastatic Cervical Cancer in Hong Kong
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today…
Vyome To Mark First Day of Trading as HIND with Nasdaq Opening Bell
Celebrates Indian Independence Day by Honoring the US-India Innovation PartnershipCAMBRIDGE, Mass.--(BUSINESS WIRE)--$HIND--Vyome…
Commuting up Mount Snowdon: FLIT M2 Shows What a Single-Speed Folding Ebike Can Do
Thursday 31 July, 2025 FLIT, the Cambridge-based ebike developer, has released a…
96% of health care executives are “ready and resourced” to use digital health solutions, yet two-thirds say interoperability is “a tough but manageable challenge,” reveals new MIT Technology Review Insights report
CAMBRIDGE, Mass., June 25, 2025 /PRNewswire/ -- A new survey report by MIT…
Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessas Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist
July 04, 2025 03:00 ET Â | Source: Nxera Pharma Tokyo, Japan and…
ReversingLabs Named to Inc.s 2025 Best Workplaces List
CAMBRIDGE, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- ReversingLabs, the trusted name…
Datalign Launches GEOs, an AI-Powered Geographic Expansion Engine for Financial Advisors
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Datalign Advisory launched GEOs, an AI-powered geographic expansion engine to…